pLVX-puro-cOVA Citations (2)
Originally described in: pLVX-OVAUnpublished
Articles Citing pLVX-puro-cOVA
| Articles |
|---|
| MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy. Deshpande RP, Wu K, Wu SY, Tyagi A, Smith EC, Kim JW, Watabe K. EMBO Mol Med. 2025 Apr;17(4):797-822. doi: 10.1038/s44321-025-00213-7. Epub 2025 Mar 14. PubMed |
| A Targetable Developmental Program Coregulates Angiogenesis and Immune Evasion in Melanoma. Berico P, Flores Yanke A, Vand-Rajabpour F, Do C, Simonin Wilmer I, Delclaux I, Muijlwijk T, Stagnitta R, Vazquez-Cruz ME, Sakellaropoulos T, Costa MR, Moraes Sousa-Squiavinato AC, Krogsgaard M, Moshiri AS, Osman I, Skok JA, Possik PA, Robles-Espinoza CD, Lund AW, Schober M, Hernando E. Cancer Discov. 2026 Jun 1;16(6):1200-1221. doi: 10.1158/2159-8290.CD-24-1853. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.